Telix Pharmaceuticals | TLX - Eps Gewinn Pro Aktie

Aktienkurs
13.95
Täglich Wechseln
0.37 2.72%
Monatlich
36.76%
Jährlich
-42.87%
Q2 Prognose
12.67

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2025H2 Dec/2025 0.36 0.14 Feb/19
FY2025H1 Jun/2025 0.02 0.27 0.09 Aug/20
FY2024H2 Dec/2024 0.14 0.10 0.05 Feb/20
FY2024H1 Jun/2024 0.09 0.15 -1874000.0000 Aug/21
FY2023H2 Dec/2023 0.05 0.05 -0.10 Feb/22




Eps Veränderung Datum
Cochlear AUD 3.13 0.25 2025-12
CSL USD 5.07 3 2025-12
Integral Diagnostics AUD 0.04 0.01 2024-12
Mayne Pharma AUD -0.15 0.74 2025-12
Medical Developments International AUD 0 0 2025-12
Mesoblast USD -0.03 0.01 2025-12
Neuren Pharmaceuticals AUD 0.12 0.06 2025-12
Pacific Edge NZD -0.02 0 2025-12
Paradigm Biopharmaceuticals AUD -0.06 0.03 2025-12
Polynovo AUD 0.01 0 2025-12
PYC Therapeutics AUD -0.04 0.01 2025-12
Ramsay Health Care AUD 0.66 0.01 2025-12
ResMed USD 2.68 0.19 2025-12
Sonic Healthcare AUD 0.53 0.04 2025-12